GCA
Greenwood Capital Associates’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.93M | Buy |
+56,884
| New | +$3.93M | 0.49% | 67 |
|
|
2024
Q4 | – | Sell |
-2,490
| Closed | -$296K | – | 254 |
|
|
2024
Q3 | $296K | Sell |
2,490
-32,974
| -93% | -$3.93M | 0.04% | 214 |
|
|
2024
Q2 | $5.06M | Buy |
35,464
+497
| +1% | +$70.9K | 0.67% | 53 |
|
|
2024
Q1 | $4.49M | Sell |
34,967
-6,428
| -16% | -$825K | 0.6% | 59 |
|
|
2023
Q4 | $4.28M | Buy |
+41,395
| New | +$4.28M | 0.55% | 63 |
|
|
2020
Q1 | – | Sell |
-26,810
| Closed | -$1.55M | – | 189 |
|
|
2019
Q4 | $1.55M | Sell |
26,810
-58,330
| -69% | -$3.38M | 0.33% | 68 |
|
|
2019
Q3 | $4.4M | Sell |
85,140
-805
| -0.9% | -$41.6K | 1.07% | 35 |
|
|
2019
Q2 | $4.39M | Buy |
+85,945
| New | +$4.39M | 1.1% | 36 |
|